Sorrento Therapeutics, Inc. filed a plan of liquidation with related disclosure statement in the US Bankruptcy Court on October 11, 2023. As per the plan filed,
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0095 USD | -5.00% |
|
-21.49% | -92.31% |
04-10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
03-15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-92.31% | 5.17M | |
+16.13% | 122B | |
+19.65% | 113B | |
+18.95% | 26.49B | |
-23.84% | 19.4B | |
-18.19% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- Joint Liquidation Plan and Disclosure Statement Filed by Sorrento Therapeutics, Inc.